OpenVSafe by OpenVAERS
Search V-safe

GBW-11811-35204

1 vaccination 7 coded responses 14 check-ins 7 free-text entries 6 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
774 / TX
Registered
2021-01-08
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-06
    Dose 1 — Moderna
  2. 2021-01-08
    Registered in v-safe
  3. 2021-01-08
    Survey response — days 1–6 daily, dose 1
    MedDRA: Anaphylactic shock — Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Headache, Fatigue or tiredness, Nausea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities
    Free text: Anaphylactic shock
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-01-08
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  5. 2021-01-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Adult check-in
  6. 2021-01-09
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  7. 2021-01-10
    Survey response — days 1–6 daily, dose 1
    MedDRA: Oropharyngeal pain, Swelling — Feeling: Fair · Fever · Headache · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Sore throat from the swelling the last 3 days
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-01-10
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  9. 2021-01-11
    Survey response — days 1–6 daily, dose 1
    MedDRA: Fatigue — Feeling: Good · Headache
    Free text: Fatigue
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-01-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache · Be unable to do your normal daily activities
    Adult check-in
  11. 2021-01-12
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  12. 2021-01-13
    Health check-in — day 7, dose 1
    Feeling: Good · Headache
    Adult check-in
  13. 2021-01-21
    Survey response — day 14, dose 1
    MedDRA: Headache — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Headaches daily. Almost migraine strength
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-01-27
    Survey response — day 21, dose 1
    MedDRA: Headache — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Headaches
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-01-27
    Report sent to call center — day 21, dose 1
    Get care from a doctor or other healthcare professional
    1 call case(s)
  16. 2021-02-05
    Health check-in — day 28, dose 1
    Feeling: Good
    Adult check-in
  17. 2021-02-10
    Health check-in — day 35, dose 1
    Feeling: Good
    Adult check-in
  18. 2021-02-16
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact
  19. 2021-02-17
    Health check-in — day 42, dose 1
    Feeling: Good
    Adult check-in
  20. 2021-04-07
    Health check-in — 3 months, dose 1
    Feeling: Good
    Adult check-in
  21. 2021-07-07
    Survey response — 6 months, dose 1
    MedDRA: Supraventricular tachycardia — Feeling: Good · Be unable to work or attend school
    Free text: SVT once
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2022-01-06
    Survey response — 12 months, dose 1
    MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Covid
    MedDRA releases: 2024-11 · check-in free text available
  23. 2022-01-06
    Report sent to call center — 12 months, dose 1
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  24. 2022-01-07

Vaccinations

DoseDateManufacturerCo-administered
12021-01-06Moderna

Call center

6 call center cases

5 successful · 1 unsuccessful

VAERS report filed, before or during a call: 6

See the call center timeline

Free text

Release 1 — days 1–6 daily, dose 1

2021-01-08

Systemic reaction (other): Anaphylactic shock

2021-01-10

Systemic reaction (other): Sore throat from the swelling the last 3 days

2021-01-11

Systemic reaction (other): Fatigue

Release 2 — day 14, dose 1

2021-01-21

Symptoms: Headaches daily. Almost migraine strength

Release 2 — day 21, dose 1

2021-01-27

Symptoms: Headaches

Release 9 — 6 months, dose 1

2021-07-07

Symptoms: SVT once

Release 10 — 12 months, dose 1

2022-01-06

Symptoms: Covid

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCOVID-19 · · ✓
SDHeadache ✓ ✓ ✓
SDSupraventricular tachycardia ✓ ✓ ✓
SROAnaphylactic shock ✓ ✓ ✓
SROFatigue ✓ ✓ ✓
SROOropharyngeal pain ✓ ✓ ✓
SROSwelling ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release